Form 4: Equillium Director Barbara Troupin Acquires 20,000 Stock Options
SEC Form 4 Filing
Director Barbara Troupin acquired 20,000 stock options in Equillium, Inc. on May 22, 2024.
Summary
- Barbara Troupin, a director of Equillium, Inc., filed a Form 4 to report changes in beneficial ownership.
- On May 22, 2024, Troupin acquired 20,000 stock options with an exercise price of $1.43.
- These options vest in twelve equal monthly installments starting from the grant date, and will be fully vested by the date of the Issuer's annual meeting of stockholders following the grant date.
- The options expire on May 22, 2034.
- Following the transaction, Troupin directly owns 20,000 derivative securities.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock option grants, indicating standard compensation practices. It doesn't inherently suggest positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The granting of stock options can align the interests of directors with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/22/2024 | Date of transaction: Director Barbara Troupin acquired 20,000 stock options. |
| 05/23/2024 | Date of Form 4 filing. |
| 05/22/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.